APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro)

Kidney Int. 2021 Jul;100(1):27-30. doi: 10.1016/j.kint.2020.11.025.

Authors

Barry I Freedman¹, Emilio D Poggio²

Affiliations

¹ Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. Electronic address: bfreedma@wakehealth.edu.
² Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Apolipoprotein L1* / genetics
Donor Selection
Genotype
Humans
Kidney Transplantation* / adverse effects
Living Donors

Substances

APOL1 protein, human
Apolipoprotein L1

Grants and funding